CT Pulmonary Angiography: Increasingly Diagnosing Less Severe Pulmonary Emboli by Schissler, Andrew J. et al.
CT Pulmonary Angiography: Increasingly Diagnosing
Less Severe Pulmonary Emboli
Andrew J. Schissler1, Anna Rozenshtein2, Michal E. Kulon2¤, Gregory D. N. Pearson2, Robert A. Green3,
Peter D. Stetson4, David J. Brenner5, Belinda D’Souza2, Wei-Yann Tsai6, Neil W. Schluger1,7,
Andrew J. Einstein1,2,8*
1Department of Medicine, Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York, United States of America, 2Department of
Radiology, Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York, United States of America, 3Department of Emergency Medicine,
Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York, United States of America, 4Department of Biomedical Informatics and
Department of Medicine, Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York, United States of America, 5Center for Radiological
Research, Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York, United States of America, 6Department of Biostatistics, Mailman
School of Public Health, Columbia University, New York, New York, United States of America, 7Division of Pulmonary, Allergy, and Critical Care Medicine, Department of
Medicine, Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York, United States of America, 8Cardiology Division, Department of
Medicine, Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York, United States of America
Abstract
Background: It is unknown whether the observed increase in computed tomography pulmonary angiography (CTPA)
utilization has resulted in increased detection of pulmonary emboli (PEs) with a less severe disease spectrum.
Methods: Trends in utilization, diagnostic yield, and disease severity were evaluated for 4,048 consecutive initial CTPAs
performed in adult patients in the emergency department of a large urban academic medical center between 1/1/2004 and
10/31/2009. Transthoracic echocardiography (TTE) findings and peak serum troponin levels were evaluated to assess for the
presence of PE-associated right ventricular (RV) abnormalities (dysfunction or dilatation) and myocardial injury, respectively.
Statistical analyses were performed using multivariate logistic regression.
Results: 268 CTPAs (6.6%) were positive for acute PE, and 3,780 (93.4%) demonstrated either no PE or chronic PE. There was
a significant increase in the likelihood of undergoing CTPA per year during the study period (odds ratio [OR] 1.05, 95%
confidence interval [CI] 1.04–1.07, P,0.01). There was no significant change in the likelihood of having a CTPA diagnostic of
an acute PE per year (OR 1.03, 95% CI 0.95–1.11, P = 0.49). The likelihood of diagnosing a less severe PE on CTPA with no
associated RV abnormalities or myocardial injury increased per year during the study period (OR 1.39, 95% CI 1.10–1.75,
P = 0.01).
Conclusions: CTPA utilization has risen with no corresponding change in diagnostic yield, resulting in an increase in PE
detection. There is a concurrent rise in the likelihood of diagnosing a less clinically severe spectrum of PEs.
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Introduction
Acute pulmonary embolism (PE) is a common disease with
potentially high morbidity and mortality [1–3]. Prompt diagnosis
and treatment with anticoagulation has been shown to improve
outcomes significantly [4]. Over the past decade, multidetector-
row computed tomography pulmonary angiography (CTPA) has
become the primary tool for the diagnosis of PE [5]. CTPA is non-
invasive, takes minutes to perform, and has very high sensitivity
and specificity [6–9]. It is therefore not surprising that CTPA
utilization has grown rapidly. National data suggests a steady
increase in the total number of computed tomography scans
performed in the emergency department (ED) [10] and several
CTPA-specific studies at individual hospital centers support these
trends [11–15].
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Increased CTPA utilization has led to a corresponding rise in
PE detection [16–18]. This has engendered growing concern
about over-diagnosis: CTPA may be detecting more PEs of
minimal clinical significance [16]. Two epidemiological studies –
one using national data and another using data from the state of
New York – showed a rise in PE incidence since the introduction
of CTPA with minimal change in mortality [16,17]. A recent study
using individual patient-based data demonstrated an increased
incidence of PE with no significant change in 7 or 14 day overall
mortality [18]. These studies suggest that we are increasingly
detecting a different, less fatal form of disease with CTPA.
This study was designed to provide additional supporting
evidence that increased CTPA utilization has resulted in an
increased detection of a less severe disease spectrum. In addition to
reviewing patterns of CTPA utilization and diagnostic yield
(percent of scans positive for an acute PE), we assessed trends in
PE disease severity, measured by the presence of right ventricular
dysfunction or dilatation on echocardiography and myocardial
injury on cardiac troponin testing. The absence of right ventricular
abnormalities and myocardial damage in patients with an acute
PE identifies a subset of patients with milder disease who could be
considered candidates for outpatient management [19].
Materials and Methods
This study was performed at NewYork-Presbyterian Hospital/
Columbia University Medical Center. The study was approved by
the Columbia University Medical Center Institutional Review
Board with a waiver of informed consent.
Data Collection and Processing
We retrospectively reviewed electronic medical records and
identified all adults (age$18 years old) who underwent CT
angiography of the chest in our ED between 1/1/2004 and 10/
31/2009. Data from 11/1/2009–12/31/2009 could not be
included because of a change in our picture archiving and
communication system (PACS). All CT angiograms were per-
formed on the same scanner (Siemens Somatom Sensation 10,
Siemens Medical Solutions USA, Inc., Malvern, PA) during the
study period. We collected data on patient age, sex, race/ethnicity,
troponin I levels, transthoracic echocardiogram (TTE) findings,
CT angiogram findings, emergency room disposition (e.g.
discharged, admitted), and mortality during hospital stay if
admitted. We also collected data on total ED visits for each year
in the study period; daily data was obtained for 2009. The data
was compiled in a MySQL database (version 5.1.43; Oracle
Corporation, Redwood Shores, CA).
A total of 5,088 CT angiograms were initially identified. All CT
angiograms ordered for an indication other than to assess for PE,
such as aortic dissection, were excluded (550 studies). A total of
323 patients underwent more than one CTPA during our study
period. For these patients, we limited our analysis to only the first
CTPA (428 studies excluded) given concern that a few patients
with multiple scans in a short period of time could bias our results.
Final radiologist reports could not be retrieved for 32 studies, and
these were re-read by an attending chest radiologist (A.R.). If the
images were not available, the study was excluded (5 studies). We
excluded technically limited studies where the presence or absence
of an acute PE was unclear to the attending radiologist dictating
the final report (57 studies). Thus, a total of 4,048 CTPAs were
included in the primary analysis.
To facilitate analysis in the context of the large percentage of
negative scans, we developed a natural language processing
algorithm in PHP: Hypertext Preprocessor (release 5.2, The
PHP Group, http://www.php.net) to categorize all CTPA final
reports as negative, positive, or unclear. All reports classified by
the algorithm as ‘‘unclear’’ and ‘‘positive’’ were manually reviewed
by one of the investigators (A.J.S.) and if there was any uncertainty
by an attending chest radiologist (A.R.). Examinations that
demonstrated evidence of an acute PE were categorized as
positive. Studies were categorized as chronic PE if described as
such by the attending radiologist in the final report (e.g. based on
clot appearance within the vessel, such as a peripheral, crescent-
shaped filling defect) [20]. Studies that showed no clear evidence
of acute PE were categorized as negative. The automated
classification of negative scans was validated by a senior radiology
resident (M.K.) and an attending chest radiologist (A.R.) who
reviewed reports from 100 randomly selected studies classified as
negative, yielding 0 errors.
We manually reviewed all TTE final reports that resulted within
3 days of a positive CTPA scan. We specifically assessed right
ventricular (RV) size and systolic function. Reports that concluded
normal or ‘‘borderline’’ RV size and normal or ‘‘borderline’’ RV
function were categorized as negative. Reports that concluded at
least ‘‘mildly’’ dilated RV or at least ‘‘mildly’’ reduced RV systolic
function were categorized as positive. Reports that were techni-
cally limited with no comment on RV size or function in the
official report were categorized as inconclusive.
We reviewed myocardial-specific troponin levels for all CTPA
scans positive for an acute PE. The peak troponin level that
resulted within 24 hours of a positive CTPA was included in the
analysis. Our hospital used 3 different assays during the study
period. We set the cutoff for a positive troponin according to the
manufacturer-determined cutoff for an acute myocardial infarc-
tion for each of the assays. Here, by ‘‘myocardial injury’’ we refer
specifically to myocardial injury as indicated by a positive troponin
test [21–24].
Statistical Analysis
All data was exported from MySQL for statistical analysis in
Stata/SE 11.0 (StataCorp, College Station, Texas). Descriptive
statistics and chi-square tests were performed to compare annual
population demographic data. We performed multivariate logistic
regression analyses controlling for patient demographics (age, sex,
race/ethnicity) to assess for any trends in CTPA utilization,
diagnostic yield, and PE disease severity.
Results
CTPA Utilization Patterns and Diagnostic Yield
Of the 4,048 CTPAs from January 1, 2004 through October 31,
2009 included in the analysis, 268 were positive for an acute PE
(6.62%), 30 were positive for a chronic PE (0.74%), and 3,750
were negative for an acute or chronic PE (92.64%).
The annualized study cohort demographic data is summarized
in Table 1. There was no significant change in the study
population with regard to sex and age during the study period.
Race/ethnicity distributions changed significantly (P,0.01) during
the study period, notably in 2009 when there was an increase in
Other and corresponding decrease in Black, Hispanic and White.
Figure 1 shows annual CTPA utilization, defined as number of
studies per 1000 ED visits, increased significantly between 2004
and 2009 (odds ratio [OR] 1.05, 95% confidence interval [CI]
1.04–1.07, P,0.01). In 2004 there were 8.0 CTPAs performed per
1000 ED visits and this increased to 10.9 in 2009.
Diagnostic yield, or percent of all analyzed CTPAs positive for
an acute PE, averaged 6.5% (range 5.5% to 7.7%, standard
deviation [SD]= 0.79) with no significant change during the study
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period (OR 1.03, 95% CI 0.95–1.11, P = 0.49). Age was associated
with an increased likelihood of a positive CTPA (OR 1.01, 95%
CI 1.01–1.02, P,0.01). Females were less likely than males to
have a positive CTPA (OR 0.76, 95% CI 0.59–0.99, P= 0.04).
There was no statistically significant relationship between race/
ethnicity and likelihood of a positive study. Table 2 contains
annualized utilization and diagnostic yield data. Table 3 summa-
rizes the association of demographic variables with diagnostic
yield.
PE Disease Severity
Of the 268 CTPAs positive for an acute PE, 184 had an
associated TTE (68.6%) and 222 had an associated troponin level
(82.8%). 162 patients (60.5%) had both a TTE and troponin level,
while 24 patients (9.0%) had neither. The likelihood of having a
TTE did not change during the study period (OR 1.03, 95% CI
0.87–1.22, P= 0.70). The likelihood of having a troponin level did
not change during the study period (OR 0.91, 95% CI 0.73–1.14,
P = 0.42). The likelihood of having both a TTE and troponin level
did not change during the study period (OR 0.98, 95% CI 0.83–
1.15, P = 0.78).
Figure 2 shows trends in PE disease severity during the study
period. In patients diagnosed with an acute PE on CTPA, there
was a significant increase in the likelihood of having less severe
disease (i.e. no RV dysfunction or dilatation or myocardial injury)
per year during the study period, adjusted for age, race/ethnicity,
and sex (OR 1.39, 95% CI 1.10–1.75, P= 0.01). There was a
downward trend in the likelihood of having either RV dysfunction
or dilatation or troponin level elevation during the study period,
adjusted for age, race/ethnicity, and sex, which approached
statistical significance (OR 0.81, 95% CI 0.66–1.01, P= 0.06).
There were no statistically significant relationships noted between
disease severity and age, sex, or race. Table 2 contains annualized
disease severity data. Table 4 summarizes the association of
demographic variables with disease severity.
All patients in our study diagnosed with an acute PE were
admitted for further management. A total of 20 patients (7.5%) out
of 268 diagnosed with an acute PE on CTPA died prior to
discharge. In-hospital mortality was 3.2% among patients with no
RV abnormalities or myocardial injury compared to a mortality
rate of 14.1% among patients with RV dysfunction and/or
dilatation and/or myocardial injury.
Sensitivity analyses excluding 2009 given the significant change
in racial demographics and incomplete dataset (November and
December were excluded) showed no significant change in our
results.
Discussion
CTPA utilization in the ED rose from 2004 to 2009 without a
significant change in diagnostic yield. As a result more PEs were
diagnosed, which is in agreement with published data that reflects
an upward trend in disease incidence [16–18]. Recent studies have
suggested this rise may be attributed to the phenomenon of ‘‘over-
diagnosis,’’ (the detection of minimally clinically significant disease
including a certain number of false positives) [16–18]. Our study
further supports this premise and demonstrates that increased
CTPA utilization has resulted in the detection of more PEs with a
less severe disease spectrum.
We used RV dysfunction or dilatation and myocardial injury as
surrogates for disease severity. The presence of RV dysfunction or
dilatation on TTE in normotensive patients signifies an increased
risk of recurrent PE and death. Multiple studies report mortality
rates between 4.3–12.8% in normotensive patients with acute PE
and RV dysfunction or dilatation, compared to less than 1% in the
absence of RV dysfunction or dilatation [19,25,26]. Unfortunate-
ly, the definition of RV dysfunction or dilatation differs in these
studies and includes various classifications [19,25,26]. It is
reasonable, though, to assume a completely normal study is
indicative of a low-risk PE.
Myocardial damage, as evident by a critically elevated troponin
I level in the setting of an acute PE, has been strongly associated
with more severe disease. Two prospective studies of patients with
acute PEs demonstrated a significant association between high
troponin levels (levels indicative of myocardial injury) and overall
mortality and complicated in-hospital course [27,28]. A more
recent retrospective study in hemodynamically stable patients
similarly noted in-hospital mortality to be significantly increased in
patients with high troponin levels compared to those with normal
Table 1. Demographic data for subjects who underwent a
CTPA in the ED.
Characteristic Study Year
2004 2005 2006 2007 2008 2009* P-value
Total CTPAs
Performed
506 626 717 736 778 685
Age (years) 0.57
Mean 53.3 53.8 55.1 54.9 54.4 54.4
SD 18.8 19.5 19.2 19.3 19.6 19.2
Race/Ethnicity (%) ,0.01
White 18.4 17.4 16.1 18.0 14.7 15.7
Black 21.8 24.1 21.4 22.5 21.8 16.9
Hispanic 29.8 31.1 32.3 30.8 28.8 21.3
Other 30.0 27.5 30.2 29.2 34.7 46.2
Sex (%) 0.90
Male 32.8 34.5 32.8 35.1 32.7 33.3
Female 67.2 65.5 67.2 65.0 67.4 66.7
*Incomplete year: includes data from Jan. 1, 2009 to Oct. 31, 2009.
doi:10.1371/journal.pone.0065669.t001
Figure 1. Annual CTPA utilization patterns. Graph shows an
increase in the number of CTPAs ordered from 2004 to 2009 with
concurrent increase in number of scans positive for an acute PE.
doi:10.1371/journal.pone.0065669.g001
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levels [29]. No significant difference in mortality was noted for
patients with only moderately elevated troponin levels when
compared to patients with normal troponin levels [29].
It should be noted that elevated troponin levels and RV
abnormalities on TTE each provide independent negative
prognostic significance [19,25,29]. The absence of RV dysfunction
or dilatation on TTE combined with a normal or only moderately
elevated troponin level identifies a patient group with a more
favorable prognosis. This subset group has a significantly lower
rate of in hospital mortality, as supported by our data, and
complications [27,29]. Our data strongly suggests that increased
detection of this ‘‘low-risk PE’’ subgroup is significantly contrib-
uting to the overall rise in PE detection.
We did not include clot burden in our analysis as recent studies
have suggested this is not predictive of short- or long-term
mortality [30,31]. The current thought is that the patient’s
underlying cardiopulmonary reserve plays a major role in how
well a given PE is tolerated. Moreover, PEs are associated with the
release of pulmonary artery vasoconstrictors that account for at
least some of the hemodynamic consequences [32].
Our data also demonstrates that older patients are more likely
have a positive CTPA. This was expected as age is a known risk
factor for the development of PE [33]. There is no statistically
significant association between age and disease severity in our
study. Interestingly, female patients are less likely to have a positive
CTPA, but when the scan is positive for acute PE, females are just
as likely as males to have less severe disease. There is no
statistically significant relationship between race/ethnicity and
diagnostic yield or disease severity.
There were a number of limitations to our study. The
retrospective design limits the data available for analysis. For
example, the hemodynamic status of our study population is
unknown. Most patients were likely hemodynamically stable since
they were able to undergo CTPA. We also do not have complete
risk-factor profiles for our study population. This does not permit
evaluation of the clinical appropriateness of the ordered CTPAs by
computing each subject’s Wells score [34,35] or Geneva score
[36]. Our diagnostic yield is consistent with those published in
Table 2. Annualized CTPA utilization, diagnostic yield and disease severity data.
Study Year
2004 2005 2006 2007 2008 2009*
Total ED visits 63357 66397 68076 70070 72430 62854
Total CTPAs performed 506 626 717 736 778 685
Positive CTPAs 28 40 51 44 60 45
Diagnostic yield (% total CTPA positive) 5.5 6.4 7.1 6.0 7.7 6.6
Total CTPAs with troponin level analyzed 25 36 39 35 49 38
CTPAs with negative troponin 18 31 36 28 44 32
% CTPAs with troponin levels analyzed with negative troponin 72.0 86.1 92.3 80.0 89.8 84.2
Total CTPAs with TTE analyzed 20 27 33 31 40 33
CTPAs with TTE demonstrating no RV abnormalities (negative) 5 8 18 12 18 15
% CTPAs with TTE analyzed with negative TTE 25.0 29.6 54.5 38.7 45.0 45.5
Total CTPAs with troponin level and TTE analyzed 18 26 27 27 36 28
CTPAs with negative troponin and negative TTE 3 7 13 10 16 13
% CTPAs with TTE & troponin level analyzed with both negative 16.7 26.9 48.1 37.0 44.4 46.4
*Incomplete year: includes data from Jan. 1, 2009 to Oct. 31, 2009.
doi:10.1371/journal.pone.0065669.t002
Table 3. Association of various demographic variables and
likelihood of a positive CTPA scan.
OR 95% CI P-value
Year 1.03 (0.95 1.11) 0.49
Age 1.01 (1.01 1.02) ,0.01
Female 0.76 (0.59 0.99) 0.04
Race Black 1 – – –
Hispanic 0.75 (0.52 1.10) 0.14
Other 1.03 (0.73 1.45) 0.88
White 0.98 (0.66 1.46) 0.93
doi:10.1371/journal.pone.0065669.t003
Figure 2. Annual number of PEs diagnosed by CTPA, number
of PEs without associated RV abnormalities or myocardial
injury, and number of PEs with associated RV dysfunction and/
or dilatation and/or myocardial injury.
doi:10.1371/journal.pone.0065669.g002
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similar studies suggesting that our ordering patterns are similar to
those at other centers in the United States [11,12,14,32]. We are
further unable to assess any changes in the ED population over
time that could have alternately increased the incidence of PE, for
example an increase in oncology patients. Approximately 39% of
subjects did not have both TTE and troponin level data for our
final analysis. The rate of ordering of these studies was stable
during the study period. We suspect that patients that did not
undergo TTE or troponin testing were more likely to have had less
severe disease. We set the cutoff for a positive troponin according
to the level indicative of myocardial infarction because one of the
assays did not permit a lower threshold. This is higher than the
cutoff used in many PE studies [37], but the data suggests that
higher troponin levels are more indicative of a worse prognosis
even when compared to moderately elevated levels [27,29]. There
exists the possibility of some imprecision when directly comparing
the cutoff points between the 3 troponin assays used in this study,
but we suspect this to be limited. We did not include CTPA
measurements of RVD as our radiologists did not consistently
assess for this during the study period. There is data to suggest that
quantitative CT parameters along with serum troponin measure-
ments can be used as an alternative to transthoracic echocardi-
ography (TTE) for the detection of RVD [38]. It is unclear why
there was a significant change in our study population race/
ethnicity demographic in 2009. This may be related to a change in
how the data was either collected or recorded, but this could not
be determined. Sensitivity analyses excluding 2009 data did not
significantly change our results. We do not discuss utilization of
other imaging modalities such as lung scintigraphy (V/Q scan)
[39], magnetic resonance angiography [40], or conventional
pulmonary angiography as our data are limited to PEs diagnosed
by CTPA. Finally, our study conclusions may not be generalizable
to all practice settings, which may vary in terms of spectrum of
pathology and diagnostic study ordering patterns.
The increase in CTPA utilization necessitates a shift in thinking
regarding the diagnosis and management of PE. As opposed to
being a ruled-in or ruled-out diagnosis, it should rather be viewed
as a disease spectrum. Some filling defects detected on CTPA are
likely either false positive results, or clinically insignificant. Other
filling defects carry high morbidity and mortality risk. Future
studies should establish if the risks of therapeutic anticoagulation
outweigh the benefits in smaller filling defects with no associated
RV abnormalities or myocardial injury in the setting of no
detectable deep venous thrombosis. Ultimately, it will be
important to develop a grading system using objective clinical
data (vital signs, laboratory data, and imaging results) with
associated clinical pathways that guide decision making, including
inpatient versus outpatient management as well as duration of
anticoagulation treatment.
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